Yong Ben

Insider Reports History

Location
Norwood, MA
Signature
/s/ Aaron Chan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yong Ben:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Corbus Pharmaceuticals Holdings, Inc. Director Common Stock, par value $0.0001 per share 2.78K $83.5K $30.00 May 30, 2024 Direct
Corbus Pharmaceuticals Holdings, Inc. Director Common Stock, par value $0.0001 per share 7.58K $56.6K $7.47 May 30, 2025 Direct
BridgeBio Oncology Therapeutics, Inc. Chief Med & Dev Officer Stock Option (Right to Buy) 357K Aug 26, 2025 Direct
Corbus Pharmaceuticals Holdings, Inc. Director Stock options (right to buy) 16K May 30, 2025 Direct

Insider Reports Filed by Yong Ben

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 26, 2025 1 $0 4 Aug 28, 2025 Chief Med & Dev Officer
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 11, 2025 0 $0 3 Aug 18, 2025 Chief Med & Dev Officer
CRBP Corbus Pharmaceuticals Holdings, Inc. May 30, 2025 2 $0 4 Jun 2, 2025 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. May 16, 2024 1 $0 4 May 20, 2024 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. May 18, 2023 1 $0 4 May 22, 2023 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Mar 6, 2023 1 $0 4 Mar 7, 2023 Director
CRBP Corbus Pharmaceuticals Holdings, Inc. Mar 6, 2023 0 $0 3 Mar 7, 2023 Director